Cynosure (CYNO) Gets FDA Clearance for Cellulaze Workstation
Up)
Cynosure, Inc. (Nasdaq: CYNO) today announced that the U.S. Food and Drug Administration has cleared the Company's Cellulaze Workstation for commercial distribution, giving millions of American women the first minimally invasive solution in their battle against cellulite.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Auxilium (AUXL) Files Suit Against Watson (WPI) Over Testim 1% Gel
- Medivation (MDVN) Submits NDA for Enzalutamide to U.S. FDA
- Repros Therapeutics (RPRX) Modifies Pivotal Androxal Protocol
Create E-mail Alert Related Categories
Corporate News, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
